US Broker Ratings

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling a Promising 18.4% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector, particularly within the medical devices industry. This Massachusetts-based company is revolutionizing organ transplant therapy..

Lantheus Holdings, Inc. (LNTH): Investor Outlook on a Potential 7.47% Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, is capturing investor attention with its promising potential upside of 7.47%. With a market..

DexCom, Inc. (DXCM) Stock Analysis: Exploring the 13.36% Potential Upside in the Medical Device Sector

DexCom, Inc. (NASDAQ: DXCM) stands as a prominent player in the healthcare sector, particularly within the burgeoning medical devices industry. With a market capitalization of $31.33..

Halozyme Therapeutics (HALO) Stock Analysis: Exploring a Biotech Gem with Robust Revenue Growth and Strong Analyst Ratings

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has been making headlines with its innovative approaches and strategic partnerships. Based in San..

Royalty Pharma plc (RPRX) Stock Analysis: A Look at Its 11.12% Upside Potential

For investors seeking exposure in the biotechnology sector, Royalty Pharma plc (NASDAQ: RPRX) offers an intriguing proposition. With a market capitalization of $33.87 billion, Royalty Pharma..

DaVita Inc. (DVA) Stock Analysis: Assessing a 20% Upside Potential in the Healthcare Sector

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services across the United States. With a market capitalization of..

Viatris Inc. (VTRS) Stock Analysis: Investor Outlook with a 13% Potential Upside

Viatris Inc. (NASDAQ: VTRS) is garnering attention in the healthcare sector, particularly among individual investors seeking opportunities in the drug manufacturing industry. With a market capitalization..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Terrain with Strategic Potential

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) presents a compelling case for investors with a keen interest in the biotech sector. Known for its pioneering work in genetic..

Roivant Sciences Ltd. (ROIV) Stock Analysis: High Analyst Confidence with a 12.58% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, is capturing investor attention with its solid market presence and innovative approach to drug..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Exploring a 33.88% Potential Upside in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (RYTM), a prominent player in the biotechnology sector, has captured the attention of investors with a compelling narrative centered around its innovative treatments..

Universal Health Services, Inc. (UHS) Stock Analysis: A 10.76% Potential Upside Beckons Investors

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, operates a diverse portfolio of acute care hospitals and behavioral health care facilities..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 39% Potential Upside Amid Robust Revenue Growth

Investors eyeing biotechnology firms for potential growth opportunities should consider BioMarin Pharmaceutical Inc. (NASDAQ: BMRN). With a market capitalization of $12.71 billion, BioMarin stands out in..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook Reveals 26.86% Upside Potential in Biotech

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a key player in the biotechnology sector, is captivating investor interest with its promising prospects in the treatment of metabolic dysfunction-associated..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unlocking a 10.95% Upside Potential in the Booming Biotech Sector

Krystal Biotech, Inc. (NASDAQ: KRYS) is making significant waves in the biotechnology sector with its innovative approach to genetic medicine. Headquartered in Pittsburgh, Pennsylvania, and boasting..

Doximity, Inc. (DOCS) Stock Analysis: Evaluating Growth Potential with a 17% Upside

Doximity, Inc. (NYSE: DOCS) is a prominent player in the healthcare sector, specifically within health information services, where it serves as a digital platform designed for..

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech Gem with 84% Upside Potential

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is capturing investor attention with its significant growth potential. With a market capitalization of..

Regencell Bioscience Holdings L (RGC): An Investor Outlook on This Niche TCM Company Amidst Volatility

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is a Hong Kong-based bioscience company that specializes in Traditional Chinese Medicine (TCM), focusing on neurocognitive disorders such as ADHD..

Cooper Companies (COO) Investor Outlook: Evaluating a 22.82% Upside Potential

The Cooper Companies, Inc. (NYSE: COO), a cornerstone in the healthcare sector, specifically within the medical instruments and supplies industry, presents an intriguing investment case for..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: 44% Upside Potential and Strong Buy Ratings

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, operates within the niche of drug manufacturers specializing in both specialty and generic..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating Performance Amidst High Valuation Metrics

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the healthcare sector, specifically within the biotechnology industry, is poised at an intriguing juncture. Despite its robust market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds